We are live on ! Find out more
CRHM

CRH Medical Corporation
CRHM

Delisted

CRHM was delisted on the 22nd of April, 2021.

40 hedge funds and large institutions have $89.1M invested in CRH Medical Corporation in 2018 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

56% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 9

24% more capital invested

Capital invested by funds: $71.8M → $89.1M (+$17.3M)

18% more funds holding

Funds holding: 3440 (+6)

Holders
40
Holders Change
+6
Holders Change %
+17.65%
% of All Funds
0.92%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
12
Increased
14
Reduced
9
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BGC
1
Beutel, Goodman & Co
Ontario, Canada
$15.8M -$440K -137,900 -3%
NCM
2
Nantahala Capital Management
Connecticut
$15.4M +$3.19M +998,421 +25%
Mawer Investment Management
3
Mawer Investment Management
Alberta, Canada
$11.6M -$6.79M -2,127,519 -36%
PRCP
4
Pacific Ridge Capital Partners
Oregon
$7.4M +$412K +129,030 +6%
Stifel Financial
5
Stifel Financial
Missouri
$6.54M -$180K -56,443 -3%
Morgan Stanley
6
Morgan Stanley
New York
$5.23M +$1.57M +491,482 +41%
SCM
7
Stadium Capital Management
Connecticut
$3.9M -$1.27M -398,485 -24%
AIMCA
8
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$3.56M -$1.58M -495,404 -36%
JP Morgan Chase
9
JP Morgan Chase
New York
$3.34M +$567K +177,600 +20%
Deutsche Bank
10
Deutsche Bank
Germany
$3.33M +$440K +137,900 +15%
Connor, Clark & Lunn Investment Management (CC&L)
11
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.85M +$1.74M +546,900 +1,222%
Canada Pension Plan Investment Board
12
Canada Pension Plan Investment Board
Ontario, Canada
$1.7M -$48.2K -15,100 -3%
Renaissance Technologies
13
Renaissance Technologies
New York
$1.19M +$385K +120,800 +46%
D.E. Shaw & Co
14
D.E. Shaw & Co
New York
$950K +$461K +144,500 +91%
ACM
15
Ativo Capital Management
Illinois
$868K +$894K +280,077 New
HIM
16
Hillsdale Investment Management
Ontario, Canada
$810K +$826K +258,900 New
CIBC World Market
17
CIBC World Market
Ontario, Canada
$722K +$743K +232,833 New
UBS Group
18
UBS Group
Switzerland
$645K +$9.68K +3,034 +1%
PP
19
Palladium Partners
Virginia
$595K
SCP
20
Seizert Capital Partners
Michigan
$436K
RA
21
Royce & Associates
New York
$416K
Royal Bank of Canada
22
Royal Bank of Canada
Ontario, Canada
$401K +$367K +115,011 +799%
MWNA
23
Marshall Wace North America
New York
$380K +$389K +121,833 New
Goldman Sachs
24
Goldman Sachs
New York
$378K +$320K +100,432 +469%
AL
25
AJO LP
Pennsylvania
$348K +$358K +112,300 New

CRHM Hedge Fund Activity: Q2 2018 in Review

40 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in CRH Medical Corporation (CRHM) for Q2 2018, worth a combined $89.1M — up 24% from $71.8M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new CRHM positions and 6 closed out — a net gain of 6 holders — while 14 added to existing stakes and 9 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $3.19M. The largest seller was Mawer Investment Management, cutting an estimated $6.79M.

  • 40 institutional investors held CRH Medical Corporation (CRHM) as of Q2 2018, up from 34 in Q1 2018.
  • Funds reported $89.1M of CRH Medical Corporation stock for Q2 2018, up 24% quarter-over-quarter.
  • 12 funds opened new CRH Medical Corporation positions in Q2 2018 and 6 closed out, a net change of +6 holders.
  • The largest CRH Medical Corporation buyer in Q2 2018 was Nantahala Capital Management, an estimated $3.19M added.
  • The largest CRH Medical Corporation seller in Q2 2018 was Mawer Investment Management, an estimated $6.79M sold.

Based on aggregated 13F filings for Q2 2018.